Maze Therapeutics Ratios (2024-2026) | MAZE

Ratios Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 91.04%
EBT Margin (Quarter) 93.85%-1,001.24%19.58%-121.04%
EBIT Margin (Quarter) 93.04%-969.16%49.90%-132.77%
EBITDA Margin (Quarter) 93.04%-969.16%49.90%-132.77%
Operating Margin (Quarter) 93.04%-969.16%49.90%-132.77%
Net Margin (Quarter) 9.26%-990.08%3.69%-121.04%
FCF Margin (Quarter) 96.44%-932.32%15.12%-195.60%
Efficiency
Assets Average (Quarter) 286.69M318.18M362.79M409.59M408.42M
Equity Average (Quarter) -333.01M-273.45M-297.86M-9.56M277.15M320.84M367.20M348.33M
Invested Capital (Quarter) -403.66M-262.37M-284.53M-311.18M292.07M262.24M379.44M354.97M380.53M
Asset Utilization Ratio (Quarter) -0.47-0.420.05
Leverage & Solvency
Interest Coverage Ratio (Quarter) -30.66
Debt to Equity (Quarter) 0.11
Debt Ratio (Quarter) 0.09
Equity Ratio (Quarter) -1.290.880.860.900.890.81
Times Interest Earned (Quarter) -30.66
Valuation
Enterprise Value (Quarter) -30.02M-175.06M-149.61M-196.81M-294.37M-264.50M-383.94M-341.92M-352.38M
Return Ratios
Return on Sales (Quarter) 0.01%-0.10%0.00%0.01%0.01%-0.01%
Return on Capital Employed (Quarter) 1.43%-57.73%-53.11%-36.92%-34.62%
Return on Invested Capital (Quarter) -0.01%-0.01%0.00%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%-0.05%0.00%0.00%0.00%0.00%